| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |